Natixis’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $43.7M | Buy |
|
|||||
2025
Q1 | $48.2M | Buy |
|
|||||
2024
Q4 | $13.4M | Sell |
|
|||||
2024
Q3 | $76.8M | Sell |
|
|||||
2024
Q2 | $111M | Buy |
|
|||||
2024
Q1 | $30.6M | Sell |
|
|||||
2023
Q4 | $58.5M | Buy |
|
|||||
2023
Q3 | $55.6M | Sell |
|
|||||
2023
Q2 | $67M | Buy |
|
|||||
2023
Q1 | $63.3M | Sell |
|
|||||
2022
Q4 | $97.1M | Buy |
|
|||||
2022
Q3 | $47.6M | Sell |
|
|||||
2022
Q2 | $57.4M | Buy |
|
|||||
2022
Q1 | $28.4M | Buy |
|
|||||
2021
Q4 | $17.7M | Sell |
|
|||||
2021
Q3 | $21.2M | Sell |
|
|||||
2021
Q2 | $74.4M | Buy |
|
|||||
2021
Q1 | $1.29M | Sell |
|
|||||
2020
Q4 | $133M | Buy |
|
|||||
2020
Q3 | $72.4M | Sell |
|
|||||
2020
Q2 | $134M | Sell |
|
|||||
2020
Q1 | $143M | Buy |
|
|||||
2019
Q4 | $140M | Buy |
|
|||||
2019
Q3 | $23.8M | Sell |
|
|||||
2019
Q2 | $129M | Buy |
|
|||||
2019
Q1 | $50M | Buy |
|
|||||
2018
Q4 | $7.92M | Sell |
|
|||||
2018
Q3 | $199M | Buy |
|
|||||
2018
Q2 | $53M | Buy |
|
|||||
2018
Q1 | $25.3M | Sell |
|
|||||
2017
Q4 | $68.1M | Buy |
|
|||||
2017
Q3 | $26.3M | Sell |
|
|||||
2017
Q2 | $24.8M | Buy |
|
|||||
2017
Q1 | – | Sell |
|
|||||
2016
Q4 | $14.4M | Buy |
|
|||||
2016
Q3 | – | Sell |
|
|||||
2016
Q2 | $4.14M | Buy |
|
|||||
2016
Q1 | – | Sell |
|
|||||
2015
Q4 | $553K | Buy |
|
|||||
2015
Q3 | $316K | Sell |
|
|||||
2015
Q2 | $1.35M | Sell |
|
|||||
2015
Q1 | $2.74M | Sell |
|
|||||
2014
Q4 | $32.2M | Buy |
|
|||||
2014
Q3 | $2.23M | Sell |
|
|||||
2014
Q2 | $7.29M | Sell |
|
|||||
2014
Q1 | $21.7M | Sell |
|
|||||
2013
Q4 | $22.4M | Sell |
|
|||||
2013
Q3 | $21.7M | Buy |
|
|||||
2013
Q2 | $15.1M | Buy |
|